Results 131 to 140 of about 22,089 (224)

Circulating HFMD-Associated Coxsackievirus A16 Is Genetically and Phenotypically Distinct from the Prototype CV-A16

, 2014
Circulating HFMD-Associated Coxsackievirus A16 Is Genetically and Phenotypically Distinct from the Prototype CV ...
Jingliang Li (13076322), Xiao-Fang Yu (248189), Wenyan Zhang (327993), Fei Sun (102854), Wanguo Bao (327991), Richard Markham (552206), Zhenhong Wei (433039), Xiaoming Hu (552205), Yulai Zhou (460655), Haoran Guo (433038), Ke Zhao (248186), Wei Wei (21173), Sangsang Ren (552204)   +12 more
core  

Cardiomyopathy Caused by Coxsackievirus Strain A9 in Previously Healthy Child, Northeastern France, 2024. [PDF]

Emerg Infect Dis
Lebreil AL, Bisseux M, Mirand A, Glenet M, N'Guyen Y, Taha N, Mauran P, Henquell C, Andreoletti L.   +8 more
europepmc   +1 more source

Coxsackievirus A21 [PDF]

, 2020
openaire   +1 more source

Optimization and Characterization of Candidate Strain for Coxsackievirus A16 Inactivated Vaccine

, 2015
Optimization and Characterization of Candidate Strain for Coxsackievirus A16 Inactivated ...
Guanchen Liu (650568), Jingliang Li (13076322), Xiao-Fang Yu (248189), Wenyan Zhang (327993), Xin Liu (43569), Junliang Chang (16796010), Jiaxin Yang (381186)   +6 more
core  

Estimating the nationwide incidence of coxsackievirus A6-associated hand, foot and mouth disease in China, 2008-2022. [PDF]

Infect Dis Poverty
Liu Y, Wang N, Liu F, Li K, Ward MP, Grassly NC, Tu W, Yu J, Li W, Zhao Y, Zhang J, Dong J, Lu T, Liu M, Chang Z, Zhang Z.   +15 more
europepmc   +1 more source

Onychomadesis: A Rare Manifestation of Coxsackievirus A6 Infection in an Adult Patient. [PDF]

Cureus
Panayiotou C, Marda A, Kyritsis G, Pagoni S, Koutete D.   +4 more
europepmc   +1 more source

Genetic Analysis of Coxsackievirus A4 Among Healthy Children - Xizang Autonomous Region, China, 1996-2024. [PDF]

China CDC Wkly
Xiao K, Hong M, Xiao M, Li F, Shao K, Zhu C, Yang L, Lin J, Wang Q, Zhuoga C, Zhu S, Yan D, Zhang Y, Li X, Xiao J.   +14 more
europepmc   +1 more source

Safety and Immunogenicity of a Vaccine Against Coxsackieviruses B (PRV-101)-Follow-up of the First-in-Human Phase 1 Trial. [PDF]

Open Forum Infect Dis
Laiho JE, Lehtonen JP, Puustinen L, Kääriäinen S, Härkönen T, Oikarinen S, León F, Sanjuan M, Scheinin M, Knip M, Hyöty H.   +10 more
europepmc   +1 more source

Establishment of severe in vitro and in vivo infection models for coxsackievirus B4 and their application in identifying viral virulence determinants. [PDF]

Virol Sin
Liu H, Xuan X, Tang B, Wang H, Zhang L, Qiu S, Mo C, Li X, Tian X, Zhou R, Liu Q, Liu W.   +11 more
europepmc   +1 more source

Humanized Murine Glioblastoma Models for Evaluation of Coxsackievirus Oncolytic Therapy. [PDF]

Cancers (Basel)
Gumennaya YD, Valikhov MP, Naberezhnaya ER, Vorobyev PO, Vadekhina VV, Alekseeva ON, Sosnovtseva AO, Kochetkov DV, Soboleva AV, Ibrahim L, Ionov SA, Yusubalieva GM, Ivanov AV, Chumakov PM, Poteryakhina AV.   +14 more
europepmc   +1 more source